Search

Katy Meyer Ebner

Examiner (ID: 7511, Phone: (571)272-5830 , Office: P/3618 )

Most Active Art Unit
3618
Art Unit(s)
3613, 3618
Total Applications
931
Issued Applications
606
Pending Applications
62
Abandoned Applications
280

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 19860860 [patent_doc_number] => 20250099646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/977672 [patent_app_country] => US [patent_app_date] => 2024-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63409 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 187 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18977672 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/977672
WOUND HEALING DRESSINGS AND FORMULATIONS AND METHODS OF USE THEREOF Dec 10, 2024 Pending
Array ( [id] => 19784095 [patent_doc_number] => 20250057774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => FAST DISSOLVING SOFTGEL CAPSULES [patent_app_type] => utility [patent_app_number] => 18/940147 [patent_app_country] => US [patent_app_date] => 2024-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9171 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940147 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/940147
FAST DISSOLVING SOFTGEL CAPSULES Nov 6, 2024 Pending
Array ( [id] => 19784095 [patent_doc_number] => 20250057774 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-20 [patent_title] => FAST DISSOLVING SOFTGEL CAPSULES [patent_app_type] => utility [patent_app_number] => 18/940147 [patent_app_country] => US [patent_app_date] => 2024-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9171 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18940147 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/940147
FAST DISSOLVING SOFTGEL CAPSULES Nov 6, 2024 Pending
Array ( [id] => 19541855 [patent_doc_number] => 20240358891 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => DEVICES AND METHODS FOR NERVE REGENERATION [patent_app_type] => utility [patent_app_number] => 18/771006 [patent_app_country] => US [patent_app_date] => 2024-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6622 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 339 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18771006 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/771006
DEVICES AND METHODS FOR NERVE REGENERATION Jul 11, 2024 Pending
Array ( [id] => 19541713 [patent_doc_number] => 20240358749 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => COMPOSITIONS FOR THE TREATMENT OF INFECTIONS IN FEET [patent_app_type] => utility [patent_app_number] => 18/765884 [patent_app_country] => US [patent_app_date] => 2024-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4322 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765884 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/765884
COMPOSITIONS FOR THE TREATMENT OF INFECTIONS IN FEET Jul 7, 2024 Pending
Array ( [id] => 19743945 [patent_doc_number] => 20250032510 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION [patent_app_type] => utility [patent_app_number] => 18/731812 [patent_app_country] => US [patent_app_date] => 2024-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18789 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18731812 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/731812
AMORPHOUS SOLID DISPERSION GANAXOLONE FORMULATION Jun 2, 2024 Pending
Array ( [id] => 19446506 [patent_doc_number] => 20240306636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => CELLULOSE NANOCRYSTAL-BASED EMULSIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/673405 [patent_app_country] => US [patent_app_date] => 2024-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5451 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18673405 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/673405
CELLULOSE NANOCRYSTAL-BASED EMULSIONS AND USES THEREOF May 23, 2024 Pending
Array ( [id] => 19570451 [patent_doc_number] => 20240374743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => BLETILLA STRIATA POLYSACCHARIDE IRON COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/660885 [patent_app_country] => US [patent_app_date] => 2024-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9017 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660885 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/660885
BLETILLA STRIATA POLYSACCHARIDE IRON COMPLEX, PREPARATION METHOD THEREFOR AND USE THEREOF May 9, 2024 Abandoned
Array ( [id] => 19846727 [patent_doc_number] => 20250092078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS [patent_app_type] => utility [patent_app_number] => 18/653604 [patent_app_country] => US [patent_app_date] => 2024-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653604 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/653604
COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS May 1, 2024 Pending
Array ( [id] => 19846727 [patent_doc_number] => 20250092078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-20 [patent_title] => COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS [patent_app_type] => utility [patent_app_number] => 18/653604 [patent_app_country] => US [patent_app_date] => 2024-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43260 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18653604 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/653604
COMPOUNDS FOR ACTIVATING INVARIANT NATURAL KILLER T-CELLS AND METHODS OF USE IN ELIMINATING INFLAMMATORY SENESCENT CELLS May 1, 2024 Pending
Array ( [id] => 19296430 [patent_doc_number] => 20240224993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => ANTIMICROBIAL COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/613465 [patent_app_country] => US [patent_app_date] => 2024-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11409 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18613465 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/613465
ANTIMICROBIAL COMPOSITIONS Mar 21, 2024 Pending
Array ( [id] => 19297528 [patent_doc_number] => 20240226093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/602972 [patent_app_country] => US [patent_app_date] => 2024-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21318 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602972 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/602972
DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF Mar 11, 2024 Pending
Array ( [id] => 19279888 [patent_doc_number] => 20240216360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/602984 [patent_app_country] => US [patent_app_date] => 2024-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21305 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18602984 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/602984
DRUG PRODUCTS FOR INTRANASAL ADMINISTRATION AND USES THEREOF Mar 11, 2024 Pending
Array ( [id] => 19769957 [patent_doc_number] => 20250051383 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYPHENYLAZO)-2-NAPHTHOL (H2AZD) FOR BIOLOGICAL APPLICATIONS [patent_app_type] => utility [patent_app_number] => 18/417989 [patent_app_country] => US [patent_app_date] => 2024-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417989 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/417989
NOVEL FEAZD, NIAZD, AND CUAZD COMPLEXES INCORPORATING 1-(2-HYDROXYPHENYLAZO)-2-NAPHTHOL (H2AZD) FOR BIOLOGICAL APPLICATIONS Jan 18, 2024 Abandoned
Array ( [id] => 19717323 [patent_doc_number] => 12202846 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-21 [patent_title] => FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)-2-naphthol (H [patent_app_type] => utility [patent_app_number] => 18/417945 [patent_app_country] => US [patent_app_date] => 2024-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 5985 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18417945 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/417945
FeAZD, NiAZD, and CuAZD complexes incorporating 1-(2-hydroxyphenylazo)-2-naphthol (H Jan 18, 2024 Issued
Array ( [id] => 19125677 [patent_doc_number] => 20240131030 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER [patent_app_type] => utility [patent_app_number] => 18/541928 [patent_app_country] => US [patent_app_date] => 2023-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 51346 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18541928 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/541928
METHODS OF TREATING B-CELL PROLIFERATIVE DISORDER Dec 14, 2023 Pending
Array ( [id] => 20212509 [patent_doc_number] => 12409143 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Softgel capsules and a method for preparing the softgel capsules [patent_app_type] => utility [patent_app_number] => 18/842531 [patent_app_country] => US [patent_app_date] => 2023-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6612 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18842531 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/842531
Softgel capsules and a method for preparing the softgel capsules Dec 12, 2023 Issued
Array ( [id] => 19125665 [patent_doc_number] => 20240131018 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-25 [patent_title] => PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB [patent_app_type] => utility [patent_app_number] => 18/523274 [patent_app_country] => US [patent_app_date] => 2023-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18948 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18523274 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/523274
PHARMACEUTICAL COMPOSITIONS OF CABOZANTINIB Nov 28, 2023 Abandoned
Array ( [id] => 19032316 [patent_doc_number] => 20240082131 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => COMPOSITION FOR IMPROVING SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/513133 [patent_app_country] => US [patent_app_date] => 2023-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4891 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18513133 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/513133
COMPOSITION FOR IMPROVING SKIN CONDITIONS Nov 16, 2023 Pending
Array ( [id] => 19135575 [patent_doc_number] => 11970505 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-04-30 [patent_title] => Pyridino-2,16-dioxapentacyclo[7.7.5.0 [patent_app_type] => utility [patent_app_number] => 18/387552 [patent_app_country] => US [patent_app_date] => 2023-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3968 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18387552 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/387552
Pyridino-2,16-dioxapentacyclo[7.7.5.0 Nov 6, 2023 Issued
Menu